Fight Back with Libby Znaimer

The Sunday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Marissa Lennox, Jane Meadus, Lisa Levin, and Miranda Ferrier on violence at nursing homes

- Mark Halpern on estate planning

- Natalie Mehra on hallway healthcare

- Dr. Steve Gallinger on pancreatic cancer

- And the best calls of the week!

The Sunday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Marissa Lennox, Jane Meadus, Lisa Levin, and Miranda Ferrier on violence at nursing homes

- Mark Halpern on estate planning

- Natalie Mehra on hallway healthcare

- Dr. Steve Gallinger on pancreatic cancer

- And the best calls of the week!

The Sunday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Marissa Lennox, Jane Meadus, Lisa Levin, and Miranda Ferrier on violence at nursing homes

- Mark Halpern on estate planning

- Natalie Mehra on hallway healthcare

- Dr. Steve Gallinger on pancreatic cancer

- And the best calls of the week!

The Saturday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Petter Muggeride and David Cravit on the Zoomer Primary

- Sgt. Dave Moffat on boat safety

- Charles Bird, Karen Stintz, and John Capobianco on this week's Strategy Panel

- John Tory, Mark Richardson, and Sgt. Kerry Schmidt on back-to-school traffic safety

- And the best calls of the week!

The Saturday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Petter Muggeride and David Cravit on the Zoomer Primary

- Sgt. Dave Moffat on boat safety

- Charles Bird, Karen Stintz, and John Capobianco on this week's Strategy Panel

- John Tory, Mark Richardson, and Sgt. Kerry Schmidt on back-to-school traffic safety

- And the best calls of the week!

The Saturday edition of the Best of Libby Znaimer’s Fight Back, from the week that was.

Interviews with:

- Petter Muggeride and David Cravit on the Zoomer Primary

- Sgt. Dave Moffat on boat safety

- Charles Bird, Karen Stintz, and John Capobianco on this week's Strategy Panel

- John Tory, Mark Richardson, and Sgt. Kerry Schmidt on back-to-school traffic safety

- And the best calls of the week!

Are you working longer than you planned to?

A new report finds the participation rate among those 65 and up has jumped to 15 per cent, or more than double the level of 10 years ago. There is little incentive to save with interest rates so low. And there’s another problem, insolvency rates for people over 65 have more than doubled in 10 years. Libby is joined by David Cravit and Laurie Campbell, CEO Credit Canada Debt Solutions.

Are you working longer than you planned to?

A new report finds the participation rate among those 65 and up has jumped to 15 per cent, or more than double the level of 10 years ago. There is little incentive to save with interest rates so low. And there’s another problem, insolvency rates for people over 65 have more than doubled in 10 years. Libby is joined by David Cravit and Laurie Campbell, CEO Credit Canada Debt Solutions.

Are you working longer than you planned to?

A new report finds the participation rate among those 65 and up has jumped to 15 per cent, or more than double the level of 10 years ago. There is little incentive to save with interest rates so low. And there’s another problem, insolvency rates for people over 65 have more than doubled in 10 years. Libby is joined by David Cravit and Laurie Campbell, CEO Credit Canada Debt Solutions.

Libby Znaimer is joined by Dr. Steven Gallinger, Hepatobiliary/pancreatic (HPB) surgical oncologist and member of the GI Site Cancer Program at Princess Margaret Cancer Centre.

Pancreatic cancer is now on track to become the third leading cause of cancer death in Canada in 2019, overtaking breast cancer.

Canadian Cancer Society spokesperson Leah Smith says "Pancreatic cancer isn't a cancer that's talked about a lot for a couple of reasons - it's only the 12th most commonly diagnosed cancer but it has one of the lowest survival rates of any cancer," says Smith.

"It's becoming an increasingly large contributor to the overall cancer burden. From a relative perspective, we're seeing it's inching its way up."